BMC Medical Informatics and Decision Making (Feb 2023)

Development of machine learning models for detection of vision threatening Behçet’s disease (BD) using Egyptian College of Rheumatology (ECR)–BD cohort

  • Nevin Hammam,
  • Ali Bakhiet,
  • Eiman Abd El-Latif,
  • Iman I. El-Gazzar,
  • Nermeen Samy,
  • Rasha A. Abdel Noor,
  • Emad El-Shebeiny,
  • Amany R. El-Najjar,
  • Nahla N. Eesa,
  • Mohamed N. Salem,
  • Soha E. Ibrahim,
  • Dina F. El-Essawi,
  • Ahmed M. Elsaman,
  • Hanan M. Fathi,
  • Rehab A. Sallam,
  • Rawhya R. El Shereef,
  • Faten Ismail,
  • Mervat I. Abd-Elazeem,
  • Emtethal A. Said,
  • Noha M. Khalil,
  • Dina Shahin,
  • Hanan M. El-Saadany,
  • Marwa ElKhalifa,
  • Samah I. Nasef,
  • Ahmed M. Abdalla,
  • Nermeen Noshy,
  • Rasha M. Fawzy,
  • Ehab Saad,
  • Abdelhafeez Moshrif,
  • Amira T. El-Shanawany,
  • Yousra H. Abdel-Fattah,
  • Hossam M. Khalil,
  • Osman Hammam,
  • Aly Ahmed Fathy,
  • Tamer A. Gheita

DOI
https://doi.org/10.1186/s12911-023-02130-6
Journal volume & issue
Vol. 23, no. 1
pp. 1 – 13

Abstract

Read online

Abstract Background Eye lesions, occur in nearly half of patients with Behçet’s Disease (BD), can lead to irreversible damage and vision loss; however, limited studies are available on identifying risk factors for the development of vision-threatening BD (VTBD). Using an Egyptian college of rheumatology (ECR)-BD, a national cohort of BD patients, we examined the performance of machine-learning (ML) models in predicting VTBD compared to logistic regression (LR) analysis. We identified the risk factors for the development of VTBD. Methods Patients with complete ocular data were included. VTBD was determined by the presence of any retinal disease, optic nerve involvement, or occurrence of blindness. Various ML-models were developed and examined for VTBD prediction. The Shapley additive explanation value was used for the interpretability of the predictors. Results A total of 1094 BD patients [71.5% were men, mean ± SD age 36.1 ± 10 years] were included. 549 (50.2%) individuals had VTBD. Extreme Gradient Boosting was the best-performing ML model (AUROC 0.85, 95% CI 0.81, 0.90) compared with logistic regression (AUROC 0.64, 95%CI 0.58, 0.71). Higher disease activity, thrombocytosis, ever smoking, and daily steroid dose were the top factors associated with VTBD. Conclusions Using information obtained in the clinical settings, the Extreme Gradient Boosting identified patients at higher risk of VTBD better than the conventional statistical method. Further longitudinal studies to evaluate the clinical utility of the proposed prediction model are needed.

Keywords